Replicating Effective Teen Pregnancy Prevention (TPP) Programs
- Response deadline
- Jul 23, 2026 Closed
- Date posted
- Jun 23, 2026
- Source
- Open notice
Description
The Office of Population Affairs (OPA) announces the anticipated availability of funds for Fiscal Year (FY) 2026 grants under the authority of Division B, Title II of the Consolidated Appropriations Act, 2026 (Public Law 119-75).This notice solicits applications for projects that provide medically accurate and age-appropriate programs that reduce teen pregnancy and advance adolescent health by strengthening body literacy, informed consent, and optimal health through the replication of effective teen pregnancy prevention (TPP) programs. Effective TPP programs are those programs that have been proven effective through rigorous evaluation to reduce teenage pregnancy, behavioral risk factors underlying teenage pregnancy, or other associated risk factors.The purpose of this Notice of Funding Opportunity (NOFO) is to support replication of effective programs that provide adolescents with medically accurate, age-appropriate education and counseling that help them understand their bodies, clarify reproductive life goals, and make informed health decisions.
Classifications
- NAICS93.297
Documents (1)
- DownloadAH-TP1-26-001 TPP Tier 1 Replication.pdfapplication/pdf728 KB
Contacts
Similar contracts
- Rigorous Impact Evaluation of Programs to Prevent Teen Pregnancy and Achieve Optimal HealthDue Jul 23, 2026
- National Training Center for Teen Pregnancy Prevention (TPP)Due Jul 10, 2026
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027
- Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not AllowedDue Apr 1, 2027
- Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)Due Jul 14, 2026